Centric Health Corp. (TSE:CRX – Free Report) – Analysts at Bloom Burton lowered their FY2024 earnings estimates for Centric Health in a research report issued to clients and investors on Monday, November 11th. Bloom Burton analyst D. Martin now expects that the company will earn ($0.04) per share for the year, down from their previous forecast of ($0.01).
CRX has been the topic of several other research reports. Stifel Canada downgraded shares of Centric Health from a “strong-buy” rating to a “hold” rating in a report on Monday, August 12th. Ventum Cap Mkts upgraded Centric Health to a “strong-buy” rating in a research note on Thursday, August 8th.
Centric Health Stock Performance
See Also
- Five stocks we like better than Centric Health
- Retail Stocks Investing, Explained
- How Whitestone REIT Is Transforming Sun Belt Retail Growth
- What is the Euro STOXX 50 Index?
- Top-Performing Non-Leveraged ETFs This Year
- Upcoming IPO Stock Lockup Period, Explained
- Rivian’s Wild Ride: Is the Dip a Buying Opportunity?
Receive News & Ratings for Centric Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centric Health and related companies with MarketBeat.com's FREE daily email newsletter.
